Native aortic valve Staphylococcus warneri endocarditis after COVID-19 infection: a case report and a review of literature

Ram Gelman; Assaf Potruch; Yonatan Oster; Yuval Ishay; Chamutal Gur; Ronen Beeri; Jacob Strahilevitz

doi:10.1111/apm.13217

Native aortic valve Staphylococcus warneri endocarditis after COVID-19 infection: a case report and a review of literature

APMIS. 2022 May;130(5):270-275. doi: 10.1111/apm.13217. Epub 2022 Mar 11.

Authors

Ram Gelman¹, Assaf Potruch¹, Yonatan Oster^{2

3}, Yuval Ishay⁴, Chamutal Gur¹, Ronen Beeri⁵, Jacob Strahilevitz^{2

3}

Affiliations

¹ Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
² Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
³ Department of Clinical Microbiology and Infectious Diseases, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
⁴ Department of Gastroenterology and Liver Diseases, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
⁵ Diagnostic Cardiology Unit, Heart Institute, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Abstract

We report a case of Staphylococcus warneri native valve endocarditis in an immunocompetent healthy adult, without known risk factors for infective endocarditis, two months following COVID-19 infection, who recovered with conservative treatment. Additionally, we reviewed previous cases of native valve endocarditis caused by Staphylococcus warneri and summarized the main clinical implications.

Keywords: COVID-19; Native valve endocarditis; coagulase-negative staphylococcal infection.

Publication types

Case Reports
Review

MeSH terms

Adult
Aortic Valve
COVID-19*
Endocarditis*
Endocarditis, Bacterial* / diagnosis
Endocarditis, Bacterial* / drug therapy
Humans
Staphylococcal Infections* / drug therapy
Staphylococcus

Supplementary concepts

Staphylococcus warneri